Since Cypress Semiconductor Corporation (NASDAQ:CY) completed the acquisition of Spansion Inc., Needham analyst Rajvindra Gill reiterated a Buy rating on CY on March 31 with a price target of …

In a research report issued today, Brean Capital analyst Jonathan Aschoff maintained a Buy rating on Soligenix Inc (OTCBB:SNGX) with a price target of $5 …

Imperial Capital analyst Bob McAdoo upgraded Hawaiian Holdings, Inc. (NASDAQ:HA) after the airlines released a note to investors before the market opened on …

After ImmunoGen, Inc. (NASDAQ:IMGN) announced that Takeda, a Japanese pharmaceutical company, will license their new cancer therapies that use novel antibody drug conjugate (ADC) technology, Oppenheimer …

Oppenheimer analyst Fadel Gheit pounded the table on EOG Resources Inc (NYSE:EOG), reiterating an Outperform rating on the oil and natural gas company. Gheit posted …

Ctrip.com International, Ltd.

Christopher Marai of Oppenheimer is optimistic going into the Dystrophin Methodology Workshop on March 20, which will be hosted by the FDA-NIH. Subsequently, the analyst …

In a research report issued on March 16, Canaccord Genuity analyst Neil Maruoka maintained a Buy rating on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) with …

In a research report published on Thursday, Axiom analyst Victor Anthony maintained a Buy rating on Twitter Inc (NYSE:TWTR) with a price target of $60, …

In a research report sent to investors on March 12, Canaccord Genuity analyst Richard Davis reiterated a Hold rating on Box Inc (NYSE:BOX) …